New Zika vaccine was made from live virus that has been inactivate and it shows effectiveness in mice.
Producing a better vaccine will require a balance between efficacy and safety of the user, vaccine produced from attenuated live viruses normally offers fast immunity but not safe.
Inactivated and subunit viruses always provide safety but may required several initial doses, safe live-atteuation vaccine will be used for production of Zika vaccine for human in developing countries.
Zika vaccine showed safety profile in mice, this vaccine will prevent transmission of the virus and microcephaly and prevent birth defects and diseases caused by Zika.
The vaccine will be recommended for women of child bearing age, their sexual partner and children less than 10 years.
No comments:
Post a Comment